|
TCHP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.281980E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.055700E-02 |
| Normal-vs-Stage2 |
4.333400E-01 |
| Normal-vs-Stage3 |
4.347200E-01 |
| Normal-vs-Stage4 |
8.041800E-02 |
| Stage1-vs-Stage2 |
7.103400E-01 |
| Stage1-vs-Stage3 |
6.501400E-01 |
| Stage1-vs-Stage4 |
5.984500E-02 |
| Stage2-vs-Stage3 |
9.802000E-01 |
| Stage2-vs-Stage4 |
9.055700E-02 |
| Stage3-vs-Stage4 |
1.148560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.296400E-02 |
| Normal-vs-AfricanAmerican |
3.480400E-02 |
| Normal-vs-Asian |
8.897200E-01 |
| Caucasian-vs-AfricanAmerican |
5.204000E-01 |
| Caucasian-vs-Asian |
5.940400E-01 |
| AfricanAmerican-vs-Asian |
4.662400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.132300E-02 |
| Normal-vs-Female |
3.697700E-02 |
| Male-vs-Female |
7.713000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.226800E-01 |
| Normal-vs-Extreme_Weight |
4.261000E-01 |
| Normal-vs-Obese |
3.323800E-02 |
| Normal-vs-Extreme_Obese |
5.918000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.607200E-01 |
| Normal_Weight-vs-Obese |
1.742820E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.191800E-01 |
| Extreme_Weight-vs-Obese |
1.652020E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.579200E-01 |
| Obese-vs-Extreme_Obese |
1.593630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.773600E-02 |
| Normal-vs-Age(41-60Yrs) |
3.079900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.031770E-01 |
| Normal-vs-Age(81-100Yrs) |
2.272200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.909200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.960200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.625700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.608990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.687700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.403220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.436500E-04 |
| Normal-VS-Type2 PRCC |
9.154600E-01 |
| Normal-VS-KIRP CIMP |
6.722400E-02 |
| Normal-VS-Unclassified PRCC |
2.442200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.142190E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.025510E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.364600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.464800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.776360E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.234300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.119200E-01 |
| Normal-vs-N1 |
4.414800E-01 |
| Normal-vs-N2 |
2.277400E-01 |
| N0-vs-N1 |
5.257400E-01 |
| N0-vs-N2 |
3.548600E-01 |
| N1-vs-N2 |
3.191800E-01 |
|
|
